Carrier | Contrast agent | Remark | Ref | Year |
---|---|---|---|---|
GO | Gd | Improved T1-weighted MRI contrast property | [17] | 2015 |
Si–Ti NPs | Gd | Improved T1-weighted MRI contrast property | [42] | 2015 |
PEG-Gd2O3 | Gd | Gd2O3 treatment with PEG-silane showed enhanced R1 relaxivity | [63] | 2007 |
Gadonanotubes | Gd | Nanotubes showed a R1/pH responsive MRI contrast properties | [64] | 2008 |
Protein-DTPA Gd | Gd | Enhanced T1 particle relaxivities | [65] | 2009 |
Gd-NPs | Gd | Superior contrast properties to commercial contrast agents | [60] | 2014 |
Gd2O3AuNPs | Gd/Au | Nanoamplifiers showed enhanced contrast | [66] | 2013 |
Gd2O3NPs | Gd | Intracellular MRI contrast agent | [67] | 2011 |
Gd–Au NCs | Gd/Au | Potential bimodal contrast agent | [68] | 2016 |
Gd–CS DTPA | Gd | In vivo and in vitro results showed enhancement in intensity of MRI signals | [69] | 2015 |